)
Ipca Laboratories (IPCALAB) investor relations material
Ipca Laboratories Q2 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Domestic formulation business grew 8% in Q2 FY26, recovering after GST rate changes in September 2025, with strong October performance.
Market share improved from 2.3% to 2.8% year-over-year, with Q2 growth of 11.6% outpacing the 7.8% market growth.
Chronic business share increased to 35%, and both acute and chronic segments outperformed the market.
Standalone net total income rose 7% year-over-year to ₹1,952.24 crore in Q2 FY26; consolidated net total income increased 9% to ₹2,584.36 crore.
Standalone net profit after exceptional items grew 25% to ₹304.74 crore; consolidated net profit after exceptional items rose 23% to ₹282.57 crore in Q2 FY26.
Financial highlights
Export formulation revenue declined 9% year-over-year to INR 493 crore in Q2, but H1 was flat at INR 941 crore.
API business grew 28% in Q2 to INR 408 crore, with full-year growth expected at 14%-15%.
Standalone EBITDA margin improved to 25.46% (from 22.89%), and consolidated EBITDA margin rose to 21.68% (from 19.1%) year-over-year.
Standalone earnings per share (EPS) after exceptional items was ₹12.01, up 25% year-over-year; consolidated EPS after exceptional items was ₹11.14, up 23%.
R&D spend increased to 3.91% of turnover in Q2, expected to remain at 4%-4.75% of turnover next year due to biosimilar and filing activities.
Outlook and guidance
Domestic growth guidance maintained at 10%-11% for FY26.
Export generics expected to grow 8%-9% in H2 FY26, with branded exports targeting 9%-10% growth for the full year.
API business guidance at 14%-15% growth for the year.
Margin guidance raised by 100 bps due to improved product mix and Unichem recovery.
Management highlighted continued growth in both domestic and export markets, with a focus on expanding API exports and maintaining strong EBITDA margins.
Next Ipca Laboratories earnings date
Next Ipca Laboratories earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage